Global Sleep Apnea Implants Market – Industry Trends and Forecast to 2031

수면 무호흡증 임플란트 시장 분석 및 규모

폐쇄성 수면 무호흡증(OSA) 치료는 수면 무호흡증 임플란트 시장을 주도하는 주요 응용 분야입니다. 이러한 임플란트는 CPAP 기계 또는 구강 기구와 같은 기존 치료법에 어려움을 겪는 중등도에서 중증의 OSA 환자를 위한 타겟 솔루션을 제공합니다. 상부 기도에 구조적 지지를 제공하고, 임플란트는 수면 중 붕괴를 방지하여 호흡 중단을 효과적으로 줄이고 수면의 질을 개선합니다. 이 응용 분야는 특히 기존 치료법을 견디거나 준수할 수 없는 환자를 위한 대체 치료법에 대한 충족되지 않은 상당한 요구를 해결하여 OSA 관리에서 전반적인 환자 치료와 결과를 향상시킵니다.

예를 들어,

2022년 2월, LivaNova PLC는 폐쇄성 수면 무호흡증(OSA) 치료를 위한 LivaNova aura6000 시스템의 안전성과 효능을 평가하기 위해 OSPREY 연구를 시작했습니다. 이 무작위 시험은 중등도에서 중증의 OSA 성인 환자를 대상으로 하며, LivaNova의 목표인 대체 OSA 관리 옵션에 대한 수요를 충족하는 데 맞춰져 있습니다.

글로벌 수면 무호흡증 임플란트 시장 규모는 2023년에 5억 1,863만 달러로 평가되었으며, 2031년까지 7억 7,152만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.09%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

수면 무호흡증 임플란트는 수면 중 기도 폐쇄로 인해 호흡이 멈추는 것을 특징으로 하는 폐쇄성 수면 무호흡증을 치료하도록 설계된 의료 기기입니다. 이러한 임플란트는 일반적으로 상부 기도에 삽입되어 구조적 지지를 제공하고 붕괴를 방지하며 중단 없는 기류를 허용합니다. 인후의 연조직을 강화하거나 지지하여 호흡 중단 발생을 줄이고 수면의 질을 개선합니다.

수면 무호흡증 임플란트 시장 동향

운전자

• 수면 무호흡증 유병률 증가로 수면 무호흡증 임플란트 도입 촉진

인식이 높아지고 더 많은 개인이 진단을 받으면서 효과적인 치료 옵션에 대한 수요가 증가합니다. 수면 무호흡증 임플란트는 지속적 양압 호흡(CPAP) 요법을 견딜 수 없거나 대안을 찾고 있는 사람들에게 유망한 솔루션을 제공합니다. 이러한 임플란트는 기도에 구조적 지지를 제공하여 수면 중 방해를 줄임으로써 작동합니다.

미국 수면 의학 아카데미의 한 기사에 따르면, 폐쇄성 수면 무호흡증의 유병률이 증가하면서 미국 성인 2,500만 명 이상이 영향을 받아 공중 보건과 안전에 중대한 위협이 되고 있습니다. 고혈압, 심장병, 2형 당뇨병, 뇌졸중, 우울증의 위험 증가를 포함한 이 질환의 해로운 영향은 효과적인 치료법에 대한 시급한 필요성을 강조합니다. 결과적으로 수면 무호흡증 임플란트에 대한 수요가 증가하면서 이 만성 질환이 제기하는 과제를 해결하기 위한 혁신적인 개입이 필요함을 보여줍니다.

• 증가하는 기술 발전으로 수면 무호흡증 치료 옵션이 향상됩니다.

Innovations such as miniaturization, wireless connectivity, and advanced sensors have improved implant effectiveness and patient comfort. These advancements enable precise monitoring and adjustment of therapy, enhancing patient outcomes. The integration of AI algorithms allows for personalized treatment strategies tailored to individual needs, further expanding the market appeal. Overall, technological progress has catalyzed the evolution of sleep apnea implants, making them more accessible and efficient for addressing this widespread sleep disorder.

Opportunities

• Increased Healthcare Investment Expand Capabilities to Diagnose and Treat Sleep Apnea Effectively

With increased funding, healthcare facilities can expand their capabilities to diagnose and treat sleep apnea effectively. This investment enables the development and adoption of innovative implant technologies designed to address sleep apnea more efficiently and with fewer side effects. As awareness about sleep disorders rises and demand for minimally invasive treatment options grows, the market for sleep apnea implants is poised for substantial growth, offering both patients and healthcare providers a promising solution for improving sleep quality and overall health outcomes.

• Enhancing Treatment Efficacy through Growing Remote Monitoring for Sleep Apnea Implants

Remote monitoring enables continuous tracking of vital parameters such as breathing patterns and oxygen levels remotely, allowing for real-time assessment of treatment effectiveness and patient well-being without the need for frequent clinic visits. This enhances convenience and comfort for patients and enables early detection of potential issues, leading to proactive interventions and improved overall outcomes. Remote monitoring facilitates personalized adjustments to treatment plans, optimizing therapeutic efficacy and potentially expanding the reach of sleep apnea management to underserved populations. As such, it represents a promising avenue for advancing the accessibility and effectiveness of sleep apnea implants.

Restraints/Challenges

• High Cost of Implantable Devices Limits the Adoption of Sleep Apnea Solutions

These implantable devices, designed to treat sleep apnea by regulating breathing during sleep, often come with substantial price tags due to their complex technology and specialized manufacturing. This cost barrier limits accessibility for patients seeking treatment, especially those without adequate insurance coverage or financial means. Consequently, the market's growth potential is hindered as affordability remains a challenge, impeding widespread adoption of these potentially life-changing solutions for sleep apnea sufferers.

• Regulatory Hurdles Limits the Availability of Sleep Apnea Implant Devices

Regulatory hurdles may include stringent testing requirements, lengthy approval processes, and compliance with safety standards, which can significantly delay product launches and increase costs for manufacturers. Additionally, regulatory uncertainty and evolving guidelines may deter investment in research and development within this market segment. Consequently, the regulatory landscape poses a formidable challenge for companies seeking to introduce innovative sleep apnea implants, impeding market growth and limiting patient access to potentially beneficial treatments.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In January 2023, NHS doctors launched a new treatment approach for sleep disorders using an innovative implant inserted into the chest of patients with sleep apnea. This implant aims to prevent the interruption of breathing during sleep, a common issue in sleep apnea, and was first implemented by Guy's and St Thomas' Health Trust (GSTT) in London
• In August 2022, StimAire Australia Pty Ltd announced a clinical trial for the StimAire Model S system, designed to treat obstructive sleep apnea (OSA) by stimulating the hypoglossal nerve. It consists of a neurostimulator and breathing sensor, aiming to reduce the apnea-hypopnea index (AHI) in patients diagnosed with moderate to severe OSA
• In June 2021, Oventus Medical collaborated with Aeroflow Healthcare to provide obstructive sleep apnea (OSA) treatment solutions directly to consumers through sleep clinics in the US. This collaboration aims to increase accessibility to Oventus' innovative solutions for managing OSA
• In February 2021, Oventus Medical launched the 02Vent Optima, a customizable oral appliance therapy device aimed at offering an alternative to CPAP therapy. Marketed through GoPAPfree in the U.S., this product provides individuals with obstructive sleep apnea (OSA) a more personalized and comfortable treatment option

Sleep Apnea Implants Market Scope

The market is segmented on the basis of product, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Hrenic nerve stimulator
• Hypoglossal neurostimulation devices
• Bone screw implant system
• Flexible tongue retractor system
• Palatal implants or pillar procedure

Indication

• Central sleep apnea
• Obstructive sleep apnea (OSA)

End User

• Hospitals
• Ambulatory surgical centers
• Office based clinics

Sleep Apnea Implants Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product, indication and end user as referenced above.

The countries covered in the market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market, primarily driven by the escalating incidence of respiratory disorders in the region. Additionally, heightened awareness surrounding sleep apnea coupled with a substantial patient population is expected to fuel market growth significantly during the forecast period. This trend underscores the region's pivotal role in advancing innovative solutions and treatment modalities for sleep-related disorders, driving sustained market expansion in the foreseeable future.

The Asia-Pacific is forecasted to experience substantial growth in the global sleep apnea implants market, primarily driven by an increasing elderly population. This demographic trend contributes to a higher prevalence of sleep disorders such as apnea. Additionally, the region's rising incidence of lifestyle diseases, often linked with sleep disorders, is expected to further boost market growth. As awareness and access to healthcare services improve, demand for advanced treatment options such as sleep apnea implants is exepcetd to rise steadily across the Asia-Pacific region in the forthcoming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Sleep Apnea Implants Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Inspire Medical Systems, Inc. (U.S.)
• LinguaFlex (U.S.)
• LivaNova PLC (U.K.)
• Medtronic (Ireland)
• Siesta Medical Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Nihon Kohden Corporation (Japan)
• Nyxoah SA (Belgium)
• ResMed (U.S.)
• Fisher & Paykel Healthcare Limited (New Zealand)
• SomnoMed (Australia)
• VYAIRE (U.S.)
• Drive DeVilbiss International (U.S.)
• Somnowell (U.K.)
• Natus Medical Incorporated. (U.S.)
• CONTEC MEDICAL SYSTEMS CO., LTD (China)
• CLEVELAND MEDICAL DEVICES INC. (U.S.)
• Nox Medical (Iceland)
• Advanced Brain Monitoring, Inc. (U.S.)  

SKU-66047